Headlands Technologies’s Centessa Pharmaceuticals CNTA Stock Holding History

Headlands Technologies’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,991	Closed	-$278K	–	763
2026 Q1	$278K	Buy	+6,991	New	+$179K	0.03%	516

Headlands Technologies's CNTA Position: Q2 2026 in Review

Headlands Technologies sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 6,991 shares — an estimated $278K sold.

Headlands Technologies first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $278K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Headlands Technologies reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Headlands Technologies sold 6,991 Centessa Pharmaceuticals shares in Q2 2026, an estimated $278K.
Headlands Technologies first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Headlands Technologies's Centessa Pharmaceuticals position peaked at $278K in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.